PyloGuard

PyloGuard™ is a dietary supplement and postbiotic designed to support the body’s natural processes for eliminating pathogens from the digestive system. It contains the patented bacterial strain Limosilactobacillus reuteri DSM17648, which attracts H. pylori and aids in its removal. The L. reuteri strain keeps H. pylori levels within the normal range and supports the overall health of the digestive system.

What are the benefits?

  • relief from pain
  • normalisation of stomach pH
  • reduction/resolution of inflammation of the gastric mucosa
  • improved digestion
  • improved absorption of vitamin B12
260 zł

30 capsules II This product does not contain: gluten, soya, lactose, preservatives, colourings or flavourings. GMO-free.

 Dispatched within 24 hours

Poprzednia najniższa cena z ostatnich 30 dni: 260.00.

Description

PyloGuard™ is a dietary supplement and postbiotic designed to support the body’s natural processes for eliminating pathogens from the digestive system. It contains the patented bacterial strain Limosilactobacillus reuteri DSM17648, which attracts H. pylori and aids in its removal. The L. reuteri strain maintains H. pylori levels within the normal range and supports the overall health of the digestive system.

How does PyloGuard work?

How does it work?

  • Supports the elimination of H. pylori
  • Supports the gut microbiome
  • Keeps H. pylori levels within normal limits

What makes this product stand out?

  • Produced using low-temperature fermentation and a drying process to prevent denaturation
  • Stable in the acidic pH of the stomach
  • Does not disrupt the gut microbiome balance
  • Formulated as a free-flowing, spray-dried powder
  • Anti-H. pylori activity supported by in vitro and in vivo scientific studies
  • Safe for long-term daily use (QPS, MIC, GRAS)
  • Manufactured and tested to exceed the most stringent EU quality standards (ISO)
  • Free from GMOs, lactose and fructose

Additional information

a beautiful young woman with vitiligo

Adults and children aged 9 and over: Dissolve 1 capsule in 180 ml of water and drink once a day on an empty stomach. For children under 9 years of age, consult a doctor or dietitian.

Do not exceed the recommended daily dose. Food supplements should not be used as a substitute for a varied diet and a healthy lifestyle.

Active ingredient: Limosilactobacillus reuteri DSM 17648

Other ingredients: silica, magnesium stearate (anti-caking agents), coating (hydroxypropyl methylcellulose, water).

20 billion CFU per capsule

Manufactured in the USA.

Pregnant and breastfeeding women, as well as parents of children under the age of 9, should consult their therapist or doctor before taking this supplement.

The product can be safely stored at room temperature. The expiry date is printed on the packaging.

The pack contains 30 capsules.

Customer reviews

There are no reviews yet.

Research

HOLZ C, BUSJAHN A, MEHLING H, ARYA S, BOETTNER M, HABIBI H, LANG C

Significant Reduction in Helicobacter pylori Load in Humans Treated with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study.

Źródło: Probiotics Antimicrobial Proteins. June 2015;7(2):91–100. doi: 10.1007/s12602-014-9181-3.
BUCKLEY M, LACEY S, DOOLAN A, GOODBODY E, SEAMANS K

The effect of Lactobacillus reuteri supplementation on Helicobacter pylori infection: a placebo-controlled, single-blind study.

Źródło: BMC Nutrition. 7 December 2018;4:48. doi: 10.1186/s40795-018-0257-4.
MEHLING H, BUSJAHN A

Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to controlling Helicobacter pylori in humans.

Źródło: Nutrients. 2013; 5(8):3062–3073. https://doi.org/10.3390/nu5083062
HOLZ C, BUSJAHN A, MEHLING H, ARYA S, BOETTNER M, HABIBI H, LANG C

Significant Reduction in Helicobacter pylori Load in Humans Treated with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study.

Źródło: Probiotics Antimicrobial Proteins. June 2015;7(2):91–100. doi: 10.1007/s12602-014-9181-3.
BUCKLEY M, LACEY S, DOOLAN A, GOODBODY E, SEAMANS K

The effect of Lactobacillus reuteri supplementation on Helicobacter pylori infection: a placebo-controlled, single-blind study.

Źródło: BMC Nutrition. 7 December 2018;4:48. doi: 10.1186/s40795-018-0257-4.
MEHLING H, BUSJAHN A

Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to controlling Helicobacter pylori in humans.

Źródło: Nutrients. 2013; 5(8):3062–3073. https://doi.org/10.3390/nu5083062
front-view-female-scientist-analysing-potion-vials_23-2148571327

Customer questions (0)

There are no questions about this product yet. Log in to ask a question.